Hexagon Capital Partners LLC Alkermes Plc. Transaction History
Hexagon Capital Partners LLC
- $508 Million
- Q3 2024
A detailed history of Hexagon Capital Partners LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 1,549 shares of ALKS stock, worth $44,874. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,549
Previous 1,537
0.78%
Holding current value
$44,874
Previous $37,000
16.22%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ALKS
# of Institutions
350Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$843 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$579 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$416 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$319 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$267 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.76B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...